Monoiodobenzoic acid compounds and their application in anti-adv7 virus
A technology of iodobenzoic acid and iodobenzoic acid, which is applied in the direction of antiviral agents, medical preparations containing active ingredients, and pharmaceutical formulas, can solve the problems of unreported inhibitory activity, and achieve easy large-scale production promotion and synthesis Simple process, economical and fast effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] [Example 1] Experiment on anti-ADV7 activity of monoiodobenzoic acid compounds L1-L3
[0031] In the present embodiment, the anti-ADV7 activity research experiment was carried out on the above-mentioned compounds, and the experimental conditions are as follows:
[0032] 1. Test content:
[0033] Analysis of compound anti-ADV7 activity: the present invention will evaluate the anti-ADV7 activity of monoiodobenzoic acid by combining cytopathic effect analysis and MTT assay cell survival rate detection method.
[0034] 2. Test method:
[0035] 2.1.1 Toxicity of compounds to host Hela cells
[0036] Plate HeLa cells in 96-well plates at 37°C, 5% CO 2 After the incubator was full of monolayers, the cell culture medium was discarded, and cell maintenance solutions containing different concentrations of test compounds were added to continue the culture. SPSS 11.5 software was used to calculate the Median cyctoxic concentration (CC50) of the drug to cells. Cell viability = ...
Embodiment 2
[0048] [Example 2] Inhibitory effect test of monoiodobenzoic acid compounds L1 and L3 on the production of ADV7 progeny virus
[0049] In the present embodiment, monoiodobenzoic acid has been carried out in-depth research on anti-ADV7 activity, and the inhibitory effect test of compounds L1 and L3 on the production of ADV7 progeny virus has been carried out. The test conditions are as follows:
[0050] 1. Test content
[0051] The inhibitory effects of compounds L1 and L3 on the virus production of ADV7 progeny were detected after ADV7 infection of Hela cells.
[0052] 2. Test method
[0053] HeLa cells in logarithmic growth phase were plated in 24-well plates, 100 TCID after confluent monolayer 50 ADV7-infected cells, incubated at 37°C for 1.5 h, removed the virus solution, washed three times with PBS, and added a cell maintenance solution containing 25 μg / mL L1 and 50 μg / mL L3. Cells and supernatant culture medium were collected after 48h, and after three freeze-thaw lysi...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com